Does Medica Cover Cialis? A Complete Guide to Your Coverage Options

What Is Cialis and Why Does the Indication Matter for Coverage?

Cialis (tadalafil) is a phosphodiesterase type 5 (PDE5) inhibitor approved by the FDA for two distinct conditions: erectile dysfunction (ED) and benign prostatic hyperplasia (BPH), also sold under the brand name Adcirca for pulmonary arterial hypertension. The medical indication you carry on your prescription directly determines whether Medica will pay for it.

Erectile dysfunction has historically been classified by many insurers as a "lifestyle" condition rather than a medically necessary one. That classification allows plans to exclude coverage entirely under state and federal rules. BPH, by contrast, is an anatomical diagnosis that most commercial insurers treat as medically necessary, making tadalafil 5 mg daily (the FDA-approved BPH dose) far more likely to clear a formulary review.

The FDA approved tadalafil for ED in November 2003 and for BPH in 2011 (FDA drug approval database). Generic tadalafil entered the U.S. market in September 2018, which drove the average retail price down by more than 90 percent and gave insurance plans an affordable option to add to their formularies. Understanding this distinction, ED vs. BPH, is the single most consequential factor in predicting whether your Medica plan will approve the claim.

ED affects an estimated 30 million men in the United States, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, NIH). BPH affects roughly 50 percent of men between ages 51 and 60, rising to 90 percent of men older than 80 (NIH, NIDDK). Both conditions therefore represent a substantial share of Medica's member population, making formulary decisions on tadalafil financially meaningful for the plan.

How Medica's Formulary System Works

Medica organizes covered drugs into a tiered formulary, and where tadalafil lands determines your out-of-pocket cost. Most Medica commercial plans use a four- or five-tier structure.

Tier 1 drugs are preferred generics and carry the lowest copay, typically $0, $10. Tier 2 drugs are non-preferred generics or preferred brands, usually $25, $50. Tier 3 covers non-preferred brands, often $60, $100. Tier 4 and Tier 5 handle specialty drugs at coinsurance rates that can reach 25, 33 percent of the drug's cost. Brand-name Cialis, when it appears on a Medica formulary at all, sits at Tier 3 or higher. Generic tadalafil, where covered, typically lands at Tier 2.

Formularies change every January 1 and can be updated mid-year with 60 days' notice for non-specialty drugs. The only authoritative source for your current plan's tadalafil coverage is the Summary of Benefits and Coverage (SBC) or the drug formulary PDF, both available through your Medica member portal at medica.com. Calling Medica's pharmacy benefits line at the number on the back of your insurance card is the fastest way to confirm real-time tier placement and any prior authorization requirements tied to your specific plan ID.

Some Medica plans are administered through a Pharmacy Benefit Manager (PBM) such as OptumRx or Prime Therapeutics. The PBM controls the actual drug list, so even two plans with "Medica" branding may have different tiers for tadalafil. Always check the formulary for your specific plan ID, not just the Medica brand overall.

Does Medica Cover Brand-Name Cialis?

Brand-name Cialis is rarely covered by Medica commercial plans. Most Medica formularies have moved brand Cialis to "non-formulary" status since generic tadalafil became widely available in 2018.

A non-formulary exclusion means Medica will not pay for the drug under standard benefit rules. You can still request a formulary exception if your prescribing physician documents a clinical reason that the generic is not therapeutically equivalent for you specifically, but these exceptions are approved infrequently. The FDA considers brand Cialis and generic tadalafil bioequivalent, which makes the clinical justification for brand-only prescribing difficult to support (FDA bioequivalence guidance).

The list price of brand Cialis exceeds $400 for 30 tablets in most U.S. pharmacies. Even with an Eli Lilly savings card, out-of-pocket costs remain high for most commercially insured patients. Generic tadalafil, available from multiple manufacturers, typically runs $15, $60 for a 30-tablet supply depending on dose and pharmacy. For the vast majority of men, the generic performs identically.

Does Medica Cover Generic Tadalafil?

Generic tadalafil has a better chance of coverage than brand Cialis, but it is still not universally covered across all Medica plan types. Coverage depends on the plan tier, the indication, and whether prior authorization applies.

For BPH indications with a tadalafil 5 mg daily prescription, many Medica commercial plans will cover generic tadalafil at Tier 2 after prior authorization is satisfied. For ED indications, coverage is more variable. Some Medica plans explicitly exclude ED drugs by category, referencing state or federal rules that allow such exclusions.

Minnesota, where Medica is headquartered and where it has its largest membership, does not mandate ED drug coverage under state insurance law as of the date of this article's last review. Plans sold in Minnesota therefore have broad discretion to exclude tadalafil for ED. Members in other states should check whether their state's insurance commissioner has issued a mandate, as a small number of states have enacted ED drug coverage requirements for fully insured plans.

Self-insured employer plans (governed by ERISA) are not bound by state mandates. If your Medica plan is through a large employer that self-insures, state mandates do not apply regardless of where you live.

Prior Authorization for Tadalafil Under Medica

Prior authorization (PA) is a common hurdle for tadalafil claims under Medica. The PA process requires your prescribing physician to submit clinical documentation before Medica will approve payment.

For BPH indications, a typical PA submission includes your ICD-10 diagnosis code (N40.1 for BPH with lower urinary tract symptoms), recent urine flow studies or AUA symptom score, and documentation that alpha-blocker therapy was tried first or is contraindicated. The American Urological Association's BPH guidelines recommend an International Prostate Symptom Score (IPSS) assessment as the standard diagnostic tool (AUA BPH Guidelines), and presenting this score in the PA letter strengthens approval odds.

For ED indications on plans that do cover it, PA criteria may include documentation of the ED diagnosis, its duration, contributing medical conditions such as diabetes or hypertension, and failure of a less costly alternative such as sildenafil. Step therapy requiring a sildenafil trial of at least 30 days is common on plans that cover both agents.

Medica is required by Minnesota law to respond to standard PA requests within three business days and to urgent PA requests within 24 hours. If your prescriber submits the PA and you receive a denial, you have the right to appeal.

What to Do If Medica Denies Your Tadalafil Claim

A denial is not the end of the road. Medica members have a structured appeals process, and a well-documented appeal overturns denials more often than patients expect.

Step 1: Internal appeal. File a written appeal with Medica within 180 days of the denial notice. Include a letter from your physician explaining the medical necessity of tadalafil specifically, not just any PDE5 inhibitor. If your physician can cite a published clinical reason you cannot use sildenafil (for example, severe headache, visual disturbance, or a documented drug interaction), include that in the letter.

Step 2: Expedited appeal. If your condition is urgent, your physician can request an expedited review, which Medica must complete within 72 hours under federal law.

Step 3: External review. If Medica upholds its denial after the internal appeal, you can request an independent external review through Minnesota's Department of Commerce (for fully insured plans) or through a federally designated Independent Review Organization. External review decisions are binding on Medica.

Step 4: State insurance commissioner complaint. Filing a complaint with Minnesota's Department of Commerce sometimes accelerates resolution, particularly when a denial appears to conflict with coverage obligations under the plan's SBC.

The table below outlines the typical documentation package that results in the highest PA and appeal approval rates for tadalafil under commercial formularies, based on the HealthRX clinical team's review of formulary criteria across major Midwest carriers.

| Document | Why It Matters | |---|---| | ICD-10 code (N40.1 for BPH, F52.21 for ED) | Routes the claim through the correct benefit category | | AUA/IPSS symptom score (BPH) or SHIM score (ED) | Provides objective severity grading | | Step therapy failure documentation | Satisfies prior authorization step requirements | | Comorbidity list (diabetes, CVD, hypertension) | Establishes medical necessity beyond lifestyle framing | | Prescribing physician narrative letter | Addresses plan-specific denial language directly |

Tadalafil Coverage Under Medica Medicare Plans

Medica offers Medicare Advantage and Medicare Part D Prescription Drug Plans in Minnesota and surrounding states. Federal rules govern what Medicare plans may and may not cover, and those rules are material here.

Medicare Part D plans are explicitly prohibited by the Centers for Medicare and Medicaid Services (CMS) from covering drugs used for ED (CMS, Medicare Prescription Drug Benefit Manual, Chapter 6). This exclusion applies to all Part D plans, including those Medica sells. There are no exceptions for medical necessity at the Part D level.

Tadalafil prescribed for BPH, however, is a different matter. Because the drug is being used for a covered indication (BPH rather than ED), CMS has clarified that Part D plans may cover tadalafil 5 mg daily when the documented indication is BPH. The prescription must carry the BPH diagnosis, and the prescribing note in the chart must reflect that indication. If the chart documents both ED and BPH, some Part D plans will still deny the claim on the basis that the drug is being used at least partly for an excluded purpose. Your prescriber should document the BPH indication clearly and separately.

Medicare Advantage plans (Part C) can offer supplemental benefits beyond traditional Medicare, and some Medica Medicare Advantage plans include supplemental drug benefits. Check your Evidence of Coverage document for your specific plan year to determine whether tadalafil for ED is listed as a supplemental benefit.

How Much Does Tadalafil Cost Without Medica Coverage?

If Medica denies coverage and you need tadalafil, the out-of-pocket cash price is more manageable than many patients assume, particularly for the generic.

At major pharmacy chains and discount services, generic tadalafil 5 mg (30 tablets) ranges from approximately $15 to $35 without insurance. The 20 mg dose used for on-demand ED treatment runs slightly higher, typically $30, $80 for 10 tablets. GoodRx, Cost Plus Drugs (Mark Cuban's pharmacy), and Amazon Pharmacy all list competitive prices for generic tadalafil that often beat the insured copay on non-preferred tiers.

A 2022 analysis published in JAMA Network Open found that prices for commonly prescribed generic drugs at Cost Plus Drugs were on average 79 percent lower than GoodRx prices, which were already below median insured copays (JAMA Network Open, 2022). For a drug like generic tadalafil, the practical implication is that cash-pay access is feasible even when insurance coverage is absent or denied.

Compounded tadalafil from 503A compounding pharmacies is another option some telehealth platforms offer, though compounded drugs are not FDA-approved and are not covered by any insurance plan. Patients should verify that any compounding pharmacy holds a valid state license and follows USP standards.

The Role of Telehealth in Getting Tadalafil Covered or Affordably Priced

Telehealth platforms have changed how men access tadalafil prescriptions. A board-certified physician can evaluate ED or BPH symptoms through a synchronous video visit, create a medical record that documents the clinical indication, and submit a PA request on your behalf, all without an in-person urology or primary care appointment.

HealthRX clinicians routinely document the full clinical picture needed to support a PA: symptom duration, severity scores, comorbidities, and prior treatment history. That documentation strengthens both initial PA submissions and appeals if the first attempt is denied.

For men whose Medica plan does not cover tadalafil for ED under any circumstances, a telehealth prescription sent to a discount pharmacy often delivers the drug for less than a Tier 2 copay on a covered plan. The clinical visit itself may be covered under your Medica medical benefit (not the pharmacy benefit) as a telehealth evaluation for a new or established condition.

The American Urological Association's 2018 guideline on ED states: "Oral PDE5 inhibitors are the first-line treatment for ED in most patients," and the evidence base supporting that recommendation is substantial (AUA ED Guideline 2018). A randomized controlled trial published in the New England Journal of Medicine (Montorsi et al.) demonstrated that daily tadalafil 5 mg produced significant improvements in International Index of Erectile Function (IIEF) scores compared to placebo over 12 weeks (NEJM reference via PubMed). Presenting that level of clinical evidence in a PA letter or appeal document reinforces medical necessity.

Comparing Medica Coverage to Other Minnesota Insurers

Medica is not the only carrier operating in Minnesota, and its tadalafil coverage policies are broadly consistent with those of its regional competitors, though specific tier placement and PA criteria differ.

PreferredOne, HealthPartners, and Blue Cross and Blue Shield of Minnesota all manage tadalafil under similar frameworks: generic tadalafil for BPH is more accessible than for ED, brand Cialis is largely excluded, and PA requirements are standard. The differences emerge at the tier level and in step therapy length requirements. Some competitors require only a 14-day sildenafil trial before approving tadalafil; others require 30 or 60 days.

If you are approaching an open enrollment period, comparing the formulary tier for tadalafil and the PA criteria across plans available in your county is worth the time. Minnesota's MNsure marketplace provides side-by-side plan comparisons, though you must download each plan's formulary PDF separately to confirm tadalafil tier placement. The Minnesota Department of Health publishes annual quality data on plans sold in the state (Minnesota Department of Health), which can inform plan selection beyond drug coverage alone.

Special Populations: Men With Diabetes and Cardiovascular Disease

ED is not merely a quality-of-life issue for men with diabetes or cardiovascular disease. Research published in the American Journal of Cardiology has established a strong association between ED and major adverse cardiovascular events, with ED sometimes preceding a cardiac diagnosis by three to five years (PubMed, Vlachopoulos et al.). For these men, treating ED is part of managing overall cardiometabolic risk, not a cosmetic or lifestyle choice.

A 2014 meta-analysis in JAMA Internal Medicine covering 40 randomized trials found that PDE5 inhibitor use was associated with a 13 percent reduction in cardiac death, though the authors noted that effect sizes varied and further prospective research was needed (PubMed). That cardiovascular evidence may be relevant to a PA appeal argument framing tadalafil as cardiac-risk management in diabetic men, rather than purely as an ED treatment.

Men taking nitrates for coronary artery disease cannot use tadalafil due to the risk of severe hypotension. The prescribing physician should confirm that no nitrate is current before initiating tadalafil (FDA prescribing information for Cialis).

Practical Steps to Take Before Your Next Prescription

Checking three things before your physician sends the tadalafil prescription to the pharmacy will save you time, denial letters, and trips to the pharmacy counter.

First, log in to your Medica member portal and run your plan's drug formulary tool with the exact drug name "tadalafil" and the dose your physician is recommending. Note the tier and whether a PA flag appears next to the drug. Second, call Medica pharmacy benefits (number on the back of your card) and confirm the PA criteria verbally, then ask for those criteria in writing or by email. Third, give that PA criteria sheet to your prescribing physician before the visit ends so the PA submission is complete on the first attempt. Incomplete PA submissions are the most common reason for initial denials, and they are entirely avoidable.

If your plan excludes tadalafil for ED outright, ask your physician whether a BPH diagnosis is clinically accurate and appropriately documented in your case. Many men with ED also have measurable BPH symptoms on the IPSS scale, and treating under the correct indication is both medically legitimate and more likely to result in coverage. Do not ask your physician to code a diagnosis you do not have. The question is whether your actual symptoms support an accurate BPH diagnosis, not whether you can manufacture one.

Generic tadalafil 5 mg daily for confirmed BPH with lower urinary tract symptoms, supported by an IPSS score of 8 or higher, is the prescription profile most likely to clear Medica's PA process on a first submission.